OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease


Protect Your Base Campaign Launches Oral Health Month with ARESTIN (Minocycline Hydrochloride) Patient Ambassadors Alex Rodriguez

Laval, QC, May 31, 2023 /PRNewswire/ — Bausch Health Companies Inc. (NYSE/TSX: BHC) and its oral health care business, OraPharma, today announced a partnership with the World Series Champions, Alex Rodriguez, launching a national awareness campaign about the gum disease epidemic and its impact.this Cover your bases Activities include educational components about the disease and encourage patients to discuss comprehensive treatment options with their dentists. The campaign launches throughout June, Oral Health Month, with Alex acting as a patient ambassador.

Experience the full interactive multichannel press release here: https://www.multivu.com/players/English/9171951-orapharma-alex-rodriguez-managing-gum-disease-awareness/

According to the American Dental Association, gum disease affects nearly 65 million Americans nationwide. More specifically, nearly half of Americans age 30 and older and 70% of Americans age 75 and older have some form of gum disease. The most common symptoms of gum disease include bleeding during or after brushing and red and swollen gums. Some studies suggest that gum disease may be associated with an increased risk of other chronic diseases throughout the body, such as diabetes and heart disease.

“Throughout my life and career, I have always put a lot of effort into prioritizing my health, which is why I was shocked when my dentist told me I had early-stage gum disease,” Rodriguez said. . “My dentist also told me that gum disease is more common in men and in the Latino community, which is why I feel it's so important for me to share my story. I'm lucky to have it caught early, and if it can happen in If it happened to me, it could happen to anyone.

While there is no cure for gum disease, it is important to consider a comprehensive treatment plan, which may include ARESTIN—an antibiotic used in conjunction with scaling and root planing (SRP) to treat periodontitis (also known as periodontitis) in adults. for gum disease). ARESTIN is used on infected areas to help fight the bacteria that cause gum disease. ARESTIN can be used as part of an overall health plan that includes good brushing and flossing habits and SRP.

You should not take ARESTIN if you are allergic to minocycline or tetracycline. If you are not sure, ask your dentist or pharmacist for a list of these medicines. Use of tetracyclines (including ARESTIN) while teeth are developing may cause permanent tooth discoloration and should not be used in children, pregnant or breastfeeding women. Please see below for additional important safety information about ARESTIN.

“This event is the first of its kind for OraPharma and we are very excited to have Alex on board to share his experience and not only help educate patients about this often misunderstood and underdiagnosed disease, but also encourage them to talk to their dentist, “explain Tom Stern, vice president and general manager of OraPharma. “We hope this campaign will help raise awareness of gum disease and empower others to take control of their dental health by finding appropriate treatment options that may help manage this serious disease.”

To learn more about treatment options and to hear Alex's story, visit www.Arestin.com.

About Arestin®

instruct
ARESTIN® (minocycline hydrochloride) Microspheres, 1 mg, for use in conjunction with scaling and root planing (SRP) procedures to treat adult patients with periodontitis (gum disease). ARESTIN® can be used as part of a comprehensive oral health plan that includes good brushing and flossing habits and SRP.

Important safety information

  • Do not take ARESTIN if you are allergic to minocycline or tetracycline. If you are not sure, ask your dentist or pharmacist for a list of these medicines. Facial swelling, itchy skin, fever, and swollen lymph nodes have been reported after using ARESTIN. Some of these reactions are serious. Tell your dentist right away if you have any signs of an allergic reaction, such as skin reactions or difficulty breathing, or have a severe sunburn reaction.
  • Use of tetracyclines (including Arestin) while teeth are developing may cause permanent tooth discoloration and should not be used in children, pregnant or breastfeeding women.
  • ARESTIN has not been studied in patients with weakened immune systems, such as those with HIV infection or diabetes, or those receiving chemotherapy or radiation therapy. Tetracyclines, including oral minocycline, have been associated with the development of an autoimmune syndrome with symptoms including joint pain, muscle pain, rash, swelling, fever, swollen lymph nodes, and general weakness. Tell your doctor about any health problems you have, including whether you have had oral candidiasis (“thrush”) in the past, and any medications you are taking.
  • In clinical studies, the most commonly reported non-dental side effects were headache, infection, flu symptoms, and pain.

We encourage you to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Click here for complete prescribing information.

About Aola Pharmaceuticals
OraPharma is a specialty pharmaceutical company dedicated to working with dental professionals to improve oral health. Founded over 25 years ago, OraPharma offers a range of treatment options for periodontal disease, malocclusion and a variety of regenerative solutions for oral surgery. For more information, please visit https://www.orapharma.com/.

About Doctoral Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global diversified pharmaceutical company whose mission is to improve people's lives through our healthcare products. Through our controlling interest in Bausch & Lomb, we develop, manufacture and sell a range of products primarily in the fields of gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals and eye health. With our leading durable brands, we are delivering on our promise to build an innovative company dedicated to advancing health around the world.For more information, please visit www.bauschhealth.com and contact us Twitter and LinkedIn.

ARE.0118.USA.23

SOURCE OraPharma



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *